Search research articles
Contact Us
Filters
Showing results (111-120 of 169) with videos related to
Page
of 17
Sort By:
Journal of Medicinal Chemistry
|
November 25, 1994
Syntheses of racemic and nearly optically pure ether lipids and evaluation of in vitro antineoplastic activities
R I Duclos, H H Chia, O H Abdelmageed, et al.
Life Sciences
|
January 1, 1996
Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand
J Romero, E García-Palomero, S Y Lin, et al.
European Journal of Pharmacology
|
November 11, 1999
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)
A N Gifford, M Bruneus, S Lin, et al.
Pharmacology, Biochemistry, and Behavior
|
April 21, 2010
Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists
P J McLaughlin, K M Winston, L A Swezey, et al.
Biochemical Pharmacology
|
June 15, 1997
Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics
J J Fernández-Ruiz, R M Muñoz, J Romero, et al.
European Journal of Pharmacology
|
February 19, 1997
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain
Y Hosohata, R M Quock, K Hosohata, et al.
Journal of Molecular Biology
|
August 19, 1994
Structure and orientation of the pore-forming peptide, melittin, in lipid bilayers
R Smith, F Separovic, T J Milne, et al.
Pharmacology, Biochemistry, and Behavior
|
July 22, 2008
Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats
T U C Järbe, B J LeMay, T Olszewska, et al.
Journal of Medicinal Chemistry
|
March 3, 1999
Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists
R Lan, Q Liu, P Fan, et al.
Synapse (New York, N.Y.)
|
October 25, 2000
Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281
M Cosenza, A N Gifford, S J Gatley, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 169) with videos related to
Sort By:
Page
of 17
Journal of Medicinal Chemistry
|
November 25, 1994
Syntheses of racemic and nearly optically pure ether lipids and evaluation of in vitro antineoplastic activities
R I Duclos, H H Chia, O H Abdelmageed, et al.
Life Sciences
|
January 1, 1996
Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand
J Romero, E García-Palomero, S Y Lin, et al.
European Journal of Pharmacology
|
November 11, 1999
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)
A N Gifford, M Bruneus, S Lin, et al.
Pharmacology, Biochemistry, and Behavior
|
April 21, 2010
Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists
P J McLaughlin, K M Winston, L A Swezey, et al.
Biochemical Pharmacology
|
June 15, 1997
Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics
J J Fernández-Ruiz, R M Muñoz, J Romero, et al.
European Journal of Pharmacology
|
February 19, 1997
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain
Y Hosohata, R M Quock, K Hosohata, et al.
Journal of Molecular Biology
|
August 19, 1994
Structure and orientation of the pore-forming peptide, melittin, in lipid bilayers
R Smith, F Separovic, T J Milne, et al.
Pharmacology, Biochemistry, and Behavior
|
July 22, 2008
Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats
T U C Järbe, B J LeMay, T Olszewska, et al.
Journal of Medicinal Chemistry
|
March 3, 1999
Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists
R Lan, Q Liu, P Fan, et al.
Synapse (New York, N.Y.)
|
October 25, 2000
Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281
M Cosenza, A N Gifford, S J Gatley, et al.
Page
of 17